Allergan PLC | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
750
1,630
3,919
14,980
4,689
5,086
Depreciation, Depletion & Amortization
1,045
2,828
5,995
6,631
7,369
6,749
Other Funds
54
37
154
141
512
6,526
Funds from Operations
1,377
2,675
5,802
2,152
4,940
6,932
Changes in Working Capital
164
432
1,272
727
934
1,292
Net Operating Cash Flow
1,214
2,243
4,530
1,425
5,873
5,640
Capital Expenditures
308
275
610
333
964
Sale of Fixed Assets & Businesses
12
14
140
33,838
7
Purchase/Sale of Investments
33
11
24
15,744
9,784
Net Investing Cash Flow
275
5,371
37,121
24,333
878
Cash Dividends Paid - Total
-
-
208
278
1,218
Issuance/Reduction of Debt, Net
800
3,005
24,693
9,799
2,884
Net Financing Cash Flow
867
3,018
33,443
25,122
4,924
Net Change in Cash
10
116
846
628
93
Free Cash Flow
1,036
2,004
4,075
1,094
5,524
Deferred Taxes & Investment Tax Credit
275
690
7,380
1,444
7,783
1,256
Net Assets from Acquisitions
15
5,562
37,510
1,199
5,290
Other Sources
3
442
883
7,772
15,153
Change in Capital Stock
122
24
9,113
14,904
310
Exchange Rate Effect
61
6
7
9
21
About Allergan
View Profile
